Skip to content.

Companies

Acquired by Apple

Acquired by Apple

Acquired by Capital D

Acquired by Capital D

Acquired by Oracle

Acquired by Oracle

Acquired by Siemens

Acquired by Siemens

Acquired by ERT Inc

Acquired by ERT Inc

IPO: AREC

IPO: AREC

IPO: ORTX

IPO: FRLN

IPO: ACHL

IPO: MGTX

Acquired by Facebook

IPO: BKNG

Explore our investments

  • Life Sciences investments
  • Investing since
    2016
    In collaboration with UCL Business
  • Total investment
    > $2bn
    Over $2bn of follow on funding for our companies
  • Public offerings
    4 IPOs
    Four Nasdaq IPOs since 2018

Featured investments

News

Today, 90% of Russell Group universities have affiliated funds as reported by Sifted

Why We’re Bullish on London University Spinouts

Read the article >
Perspectives

AlbionVC year in review

Read the article >
Perspectives
HTBC Techbio Sess. 3: exploring the business strategies powering the techbio revolution

Reflection on HTBC Techbio Session 3

Read the article >
Companies
  • Achilles Therapeutics
    https://achillestx.com/
    Biopharmaceutical company developing precision T cell therapies
    Sector: Life Sciences
    Status: IPO
  • Apollo Therapeutics
    https://apollotherapeutics.com/
    biopharmaceutical company advancing a robust pipeline of potentially transformative therapeutic programs
    Sector: Life Sciences
    Status: Growth
  • Axovia Therapeutics
    https://axoviatherapeutics.com/
    Gene therapy company developing disease-transformative medicines for ciliopathies
    Sector: Life Sciences
    Status: Early Stage
  • Bloomsbury GTX
    https://bloomsburygtx.com/
    Biotechnology company developing potentially curative treatments for patients suffering from rare neurological and metabolic diseases
    Sector: Life Sciences
    Status: Early Stage
  • EpilepsyGTx
    https://www.epilepsygtx.com/
    Biotechnology company developing of cutting-edge gene therapies to treat focal refractory epilepsy
    Sector: Life Sciences
    Status: Early Stage
  • Epsilogen
    https://epsilogen.com/
    Immuno-oncology company targeting cancer with the IgE class of antibodies
    Sector: Life Sciences
    Status: Early Stage
  • Meira GTX
    https://meiragtx.com/
    Vertically integrated, clinical stage gene therapy company
    Sector: Life Sciences
    Status: IPO
  • NovalGen
    https://www.novalgen.com/
    Immuno-oncology company developing breakthrough bispecific therapies that can safely harness the immune system to fight cancer
    Sector: Life Sciences
    Status: Early Stage
  • Orchard Therapeutics
    https://www.orchard-tx.com/
    Biotechnology company bringing transformative gene therapies to patients with serious and life-threatening orphan diseases
    Sector: Life Sciences
    Status: IPO
  • Panangium Therapeutics
    Biologic for retinal disease targeting a novel alternative pathway to VEGF
    Sector: Life Sciences
    Status: Early Stage
  • Quell Therapeutics
    https://quell-tx.com/
    Cell therapy immunology biotech committed to transforming patient's lives in solid organ transplantation and auto-immune conditions
    Sector: Life Sciences
    Status: Growth
  • Spur Therapeutics
    https://spurtherapeutics.com/
    Biopharmaceutical company focused on the development of liver-directed gene therapies
    Sector: Life Sciences
    Status: IPO

Let’s talk